Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Showcase Companies

Stockhouse is proud to showcase a portfolio of companies that we are watching closely. Learn more about these companies as part of your own investment research. Consider using the tools below to be first in line for important news and updates. view all showcase companies

Nanalysis Scientific Corp. V.NSCI

Nanalysis develops and manufactures compact MRI and NMR devices for clinical, laboratory, and industrial markets. These portable devices require no liquid helium or any other cryogens. The company’s devices are used in diagnostics and chemical analysis across a range of industries (medical, pharma, biotech, mining, oil and gas, and more) as well as numerous government and university research labs around the world.

Latest News

Nanalysis Announces Fourth Quarter and Full Year 2023 Results


/C O R R E C T I O N -- Nanalysis Scientific Corp./


Nanalysis Announces Full Year 2023 Conference Call


Nanalysis Scientific Corp. Announces Director Resignation


Nanalysis Corp. Receives Funding Supporting AI Software Development for Detection of Illicit...


NANALYSIS ANNOUNCES CLOSING OF PREVIOUSLY ANNOUNCED BEST EFFORTS PROSPECTUS EXEMPT OFFERING...


Canadian Investment Regulatory Organization Trade Resumption - NSCI


Canadian Investment Regulatory Organization Trading Halt - NSCI


NANALYSIS ANNOUNCES UP TO $5.0 MILLION BEST EFFORTS PROSPECTUS EXEMPT OFFERING PURSUANT TO THE...


Nanalysis Announces Upcoming Webinar and Conference Participation


Nanalysis Achieves Record Revenue in Q4


Nanalysis Scientific Corp. Provides Update on Security Services Business


Nanalysis Scientific Corp. Announces Grant of Restricted Share Units


Nanalysis Reports Third Quarter 2023 Results


Nanalysis Announces Third Quarter 2023 Conference Call